Exam 2 Musculoskeletal Diseases Flashcards

1
Q

What is scleroderma?

A

Inflammation and autoimmune disease that causes vascular injury and vascular obliteration. Chronic hardening and tightening of the skin and connective tissues.

Tissue fibrosis and organ sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 forms of scleroderma?

A
  1. Localized scleroderma- skin, face, distal limb
  2. Limited cutaneous systems sclerosis - CREST syndrome, has prominent skin manifestations
  3. Diffuse cutaneous system sclerosis- generalized skin involvement and cardiac complications.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The limited symptoms of scleroderma are referred to as CREST. What does CREST stand for?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

S/S of Scleroderma
Skin:
MS:
Nervous System:
CV:

A

Skin: Taut skin
MS: Limited mobility/contractures, skeletal muscle myopathy
Nervous System: Nerve compression
CV: Systemic and pulmonary HTN, dysrhythmias, vasospasm in small arteries of fingers, CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

S/S of Scleroderma
Pulmonary:
Renal:
GI:

A

Pulmonary: Diffuse interstitial pulmonary fibrosis, decreased pulmonary compliance (stiff lungs)
Renal: Decreased renal blood flow and systemic HTN
GI: Xerostomia, poor dentition, fibrosis of GI tract (no Reglan, will not stimulate fibrotic GI tract), reflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Scleroderma Treatment

A

Alleviating symptoms…
ACE inhibitors for renal protection - only treatment that has been proven to alter the course of scleroderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SclerodermaAnesthesia Management and Considerations
Airway:
IV:
Pulmonary:
GI:
Eyes:
Other:

A

Airway: Mandibular motion, small mouth opening, neck ROM (do not manipulate neck while asleep), oral bleeding

CV: IV/arterial line access may be difficult, use US.

Pulmonary: Decreased pulmonary compliance and reserve, avoid increasing PVR (do not make them hypoxic)

GI: Aspiration caution, increase gastric pH by using PPI.

Eyes: tape eyes, ointment, gauze, goggles

Other: Regional anesthesia may be best for these patients, keep patient warm, VTE prophylaxis, Positioning with care, Pulse ox difficulties (ear probe)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Pseudohypertrophy Muscular Dystrophy/ Duchenne Muscular Dystrophy (DMD)

A

Mutation in the dystrophin gene (x-linked recessive) causes fatty infiltration leading to pseudohypertrophic muscles.
Common in 2-5 y/o boys
By age 8-10 Wheelchair bound
Usually live until ages 20-25 years (CHF, pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Initial symptoms of Duchenne Muscular Dystrophy

A

Initial symptoms: waddling gait, frequent falling, difficulty climbing stairs, tiptoes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Duchenne Muscular DystrophyS/S
CNS:
MS:
CV:
Pulmonary:
GI:

A

CNS: Intellectual disability

MS: Kyphoscoliosis, skeletal muscle atrophy, serum CK 20-100x normal d/t increase muscle permeability

CV: Sinus tachycardia, cardiomyopathy, EKG abnormalities (tall R-wave in V1)

Pulmonary: OSA, weakened respiratory muscles, and cough

GI: Hypomotility, gastroparesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Duchenne Muscular DystrophyAnesthesia Management
Airway:
Pulmonary:
CV:
GI:

A

Airway: weak laryngeal reflexes and cough (You want these patients “singing” on the tube during emergence.)

Pulmonary: weakened muscles

CV: Pre-op EKG and/or echo based on the severity

GI: Delayed gastric emptying, aspiration risk
Avoid succ d/t risk of rhabdo, hyperkalemia, MH or cardiac arrest
Regional>GA, Keep them awake if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other anesthesia management for Duchenne Muscular DystrophyAnesthesia:

What drug do you want to avoid?

When do you want to extubate these patients?

What type of incidence are higher in these patients?

What type of anesthesia may be best?

A

Avoid succinylcholine can cause hyperkalemia and rhabdomyolysis. Use NDMR (Rocuronium).

Pharyngeal and respiratory muscle weakness, secure the airway. Make sure the patient is fully awake.

MH – increased incidence. Have Dantrolene ready. Use TIVA as an alternative

Regional Anesthesia may be best than GA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Myasthenia Gravis?

A

A chronic autoimmune disorder involving the NMJ. There will be decreased functional post-synaptic AChreceptors.

Muscle weakness w/ rapid exhaustion of voluntary muscles. Partial recovery with rest.

ACh receptor-bindingantibodies are linked to thymus abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Myasthenia GravisS/S
Eyes:
Oral:
Pulmonary:
Skeletal:
Heart:
Endocrine:

A

Ptosis (droopy eyelid), diplopia (double vision)

Dysarthria (slurred speech), dysphagia, and difficulty handling saliva

Isolated respiratory failure (rare)

Arm, leg, or trunk muscle weakness

Myocarditis

Autoimmune diseases associated
RA, SLE, pernicious anemia, hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differentiate between Myasthenia GravisMyasthenic Crisis vs Cholinergic Crisis.

What is the effect of the Edrophonium/Tensilon Test in each condition?

A

Myasthenic crisis:
D/t drug resistance or insufficient drug therapy
S/S: severe muscle weakness and respiratory failure

Cholinergic crisis (SLUDGE):
D/t excessive anticholinesterase treatment
S/S: muscarinic side effects – profound muscle weakness, salivation, miosis, bradycardia, diarrhea, abdominal pain

Edrophonium/Tensilon Test:
1-2 mg IVPof edrophonium will improve the myasthenic crisis and makes the cholinergic crisis worse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myasthenia GravisTreatment
Anticholinesterases (first-line treatment):
Thymectomy (when will you see results):
Immunosuppression:
Immunotherapy:

A

Anticholinesterases:
The first line of treatment
Pyridostigmine last longer than neostigmine

Thymectomy: helps reduce flareups, crisis, reduce medication. Reduces Ach receptor antibody level post procedure
Induces remission
Reduced use of immunosuppressives
Reduces ACh receptor antibody levels
Full benefit delayed (2-6 months)

Immunosuppression
Corticosteroids, azathioprine, cyclosporine, mycophenolate. *when weakness not controlled by anticholinergics

Immunotherapy (short-term effect)
Plasmapheresis will remove antibodies from circulation.
Immunoglobulin will have a temporary effect.

17
Q

Myasthenia GravisAnesthesia Management

Weakened ________ effort

Marked sensitivity to ______

Resistance to ____________

A

Weakened pulmonary effort (Aspiration risk)

Marked sensitivity to nondepolarizing muscle relaxants (decrease amount). Use nerve stimulator and titrate to nerve stimulator

Resistance to succinylcholine (might need a higher dose for effect, but this can lead patients into MG Crisis, just avoid using Sux)

18
Q

What is Osteoarthritis?

The is the most common joint disease in the ____?

OA is characterized by _________ inflammation.

Does stiffness fade throughout the day?

A

Degenerative process affecting articular cartilage, the most common joint disease in the elderly.

Characterized by minimal inflammation usually a result of chronic joint trauma (sports), biomechanical stresses, joint injury, abnormal joint loading, neuropathy, ligament injury, muscle atrophy, and obesity.

Pain present with motion,relieved by rest. Morning stiffness fades throughout the day. (T-rex)

19
Q

What joints will osteoarthritis affect?

A

Weight-bearing and distal interphalangeal joints.
Heberden nodes- Distal interphalangeal joints, first knuckle (pictured)

Protrusion of the nucleus pulposus (herniated disc) can lead to compression of nerve roots.

Degenerative disease – vertebral bodies and intervertebral disks. OA will affect the breakdown of the cartilage of the joints and discs in the neck and lower back. Middle to lower C-spine and L-spine.

20
Q

OsteoarthritisTreatment

A

PT and exercise

Maintaining muscle function

Pain relief - heat, simple analgesics, anti-inflammatory drugs, transcutaneous nerve stimulator, acupuncture. OA patients are typically NOT on steroids

Joint replacement surgery - necessary when pain is debilitating

21
Q

OsteoarthritisAnesthesia Management

A

Airway
Be aware of limited ROM, and keep them comfortable.
Document the patient’s position on the OR table.
Don’t lean on the patient.

22
Q

What is Rheumatoid Arthritis?

A

An autoimmune-mediated, systemic inflammatory disease that usually affects the proximal interphalangeal and metacarpophalangeal joints (2nd & 3rd knuckle).

Rheumatoid nodules at pressure points (elbows)

Rheumatoid factor (IG antibody present in 95% of patients with RA)

23
Q

Characteristics of Rheumatoid Arthritis

A

Single or multiple joints

Painful synovial inflammation, swelling, and increased fluid

Morning stiffness like OA, but remains stiff throughout the entire day.

Symmetrical distribution of several joints.

Fusiform swelling - Joints become enlarged and the fingers crooked (pictured)

Synovitis of the temporomandibular joint (decrease mouth opening)

Affects nearly all joints (except the t-spine and lumbosacral spine)

24
Q

Rheumatoid Arthritis S/S
Atlantoaxial subluxation:
Cricoarytenoid arthritis:
Osteoporosis
NM

A

Atlantoaxial subluxation instability (C1 and C2): Odontoid process (dens) protrudes into the foramen magnum. The instability can place pressure on the transverse ligament and spinal cord. Instability can also impair vertebral artery blood flow.

Cricoarytenoid arthritis:
Acute – hoarseness, dyspnea, and stridor w/ tenderness over the larynx; swelling and redness of arytenoids
Chronic – asymptomatic or variable degrees of hoarseness, dyspnea, and upper airway obstruction

Osteoporosis: More common in women than men

NM: Weakened skeletal muscles (peripheral neuropathies)

25
Q

Rheumatoid ArthritisS/S
CV:
Pulmonary:
Hematology:
Dryness:

A

CV: Pericarditis, accelerated coronary atherosclerosis
Pulmonary: Restrictive lung changes, decrease Vt
Hematology: anemia, neutropenia, elevated platelets
Dryness: Keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth)

26
Q

Rheumatoid ArthritisTreatment

A

NSAIDS
Corticosteroids
DMARDs May take 2-6 months to see effects

Tumor necrosis factor (TNF-alpha) inhibitors and interleukin(IL-1) inhibitors.
TNF-alpha inhibitors work faster than DMARDs.
IL-1 inhibitors – slower onset and less effective.

Surgery is usually held off until the patient is in intractable pain, has impairment ofjoint function, and is in need of jointstabilization. Usually a total replacementsurgery.

27
Q

Rheumatoid ArthritisAnesthesia Management

A

Airway- Atlantoaxial subluxation ,TMJ limitation, Cricoarytenoid joints. (handle w/care)

Severe rheumatoid lung disease

Protect eyes - Keratoconjunctivitis sicca (dry eyes)

Stress dose - give before surgery, may have a decrease amount of endogenous cortisol.

28
Q

What is Systemic Lupus Erythematosus?

Typical Manifestation:

A

Multisystem chronic inflammation characterized by antinuclear antibody production.

Typical manifestations (Usually will have 3 out 5 of the following):
1. Antinuclear antibodies
2. Malar rash (butterfly rash)
3. Thrombocytopenia
3. Serositis- inflammation of a serous membrane around the organ
5. Nephritis

29
Q

Systemic Lupus ErythematosusS/S
Join/Spine:
CNS:
CV:
Pulmonary:
Renal:

A

Joint/Spine: Polyarthritis and dermatitis, symmetrical arthritis (most common sx), no spinal involvement, avascular necrosis of the femoral head or condyle

CNS: Cognitive dysfunction, psychological changes

CV: Pericarditis, coronary atherosclerosis, Raynaud’s

Pulmonary: Lupus pneumonia, restrictive lung disease, vanishing lung syndrome

Renal: Glomerulonephritis, decreased GFR, risk of renal failure

30
Q

Systemic Lupus ErythematosusS/S
GI/Liver:
NM:
Hematology:
Skin:

A

GI/Liver: ABD pain, pancreatitis, elevated liver enzymes

NM: Skeletal muscle weakness

Hematology: Thromboembolism, thrombocytopenia, hemolytic anemia,

Skin: Butterfly-shaped malar rash, discoid lesions, alopecia

31
Q

Systemic Lupus ErythematosusTreatment

A

NSAIDs or ASA - will treat arthritis and serositis

Anti-malarial (Hydroxychloroquine and quinacrine) - will treat arthritis and dermatological manifestations

Corticosteroids- By reducing inflammation, corticosteroids can help to improve the production and survival of platelets in the bone marrow.

Immunosuppressants will be used if steroids are not effective (Methotrexate, azathioprine)

32
Q

Systemic Lupus ErythematosusAnesthesia Management

A

Based upon manifestations and organ dysfunction

Airway: recurrent laryngeal nerve palsy (common), cricoarytenoid arthritis

Stress dose of corticosteroids

33
Q

What is recurrent laryngeal nerve palsy?

How does lupus cause recurrent laryngeal nerve palsy?

A

A condition where the nerve that controls the muscles of the larynx (voice box) is damaged, which can lead to problems with speaking, breathing, and swallowing.

In lupus, the immune system attacks healthy tissues, including the nerves. This can lead to inflammation of the laryngeal nerve or blood vessels, which can cause them to become compressed or damaged.

34
Q

What is Malignant Hyperthermia?

A

Hypermetabolic syndrome involving a genetic mutation to the Ryanodine receptor - RYR1 gene or Dihydropyridine receptor

Caused by exposure to inhaled VA and succinylcholine (50% mortality, investigate family history)

Uncontrolled elevation of sarcoplasmic calcium
Sustained activation of muscle contraction
Rhabdomyolysis

35
Q

Malignant HyperthermiaNon-triggering Agents

A
36
Q

Malignant HyperthermiaS/S

A

Early Sign: Masseter, Acidosis, T-peaked, CO2 increase, HR increase, Rigidity, RR increase. MATCHRR

37
Q

Malignant HyperthermiaTreatment

A

D/C all triggering gas/drugs
Hyperventilate with 100% O2 at 10 L/min
Change breathing circuit and soda lime

Dantrolene (Have someone else do this, hard to mix)
20 mg + 3 G mannitol (Mix with 60 mL sterile water)
Initial dose 2.5 mg/kg
Max upper limit 10 mg/kg

Treat arrhythmias

ICE, cool them down

Monitor urine output

38
Q

Malignant HyperthermiaPost-Op

A

Transfer to ICU 24-48 hours

Report to MH registry

MH testing for pt and family members:
Muscle biopsy contracture testing (Halothane plus caffeine contracture test)

39
Q

What type of anesthesia would be used if you know the patient has a history of MH?

A

Use TIVA and go slow.